Posted on Friday, February 14, 2014 at 9:09 am CST
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 2:43 pm CST
Global Market Direct's pharmaceuticals report, "Bolder Biotechnology, Inc. - Product Pipeline Review - 2013" provides data on the Bolder Biotechnology, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 2:42 pm CST
Global Markets Direct's, 'Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL). Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 2:35 pm CST
Global Market Direct's pharmaceuticals report, "Adienne Pharma & Biotech - Product Pipeline Review - 2013" provides data on the Adienne Pharma & Biotech's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 2:16 pm CST
Global Market Direct's pharmaceuticals report, "Orexo AB - Product Pipeline Review - 2013" provides data on the Orexo AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 1:41 pm CST
Global Market Direct's pharmaceuticals report, "InVasc Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the InVasc Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 1:29 pm CST
Global Markets Direct's, 'Progressive Supranuclear Palsy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Progressive Supranuclear Palsy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy. Progressive Supranuclear Palsy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 1:11 pm CST
Global Market Direct's pharmaceuticals report, "Hygeia Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the Hygeia Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:59 pm CST
Global Market Direct's pharmaceuticals report, "AUS Bio Limited - Product Pipeline Review - 2013" provides data on the AUS Bio Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:56 pm CST
Global Market Direct's pharmaceuticals report, "NeuroHealing Pharmaceuticals Inc. - Product Pipeline Review - 2013" provides data on the NeuroHealing Pharmaceuticals Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:18 pm CST
Global Markets Direct's, 'Dilated Cardiomyopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dilated Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dilated Cardiomyopathy. Dilated Cardiomyopathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:17 pm CST
Global Markets Direct's, 'General Anxiety Disorder - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for General Anxiety Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for General Anxiety Disorder. General Anxiety Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:14 pm CST
Global Market Direct's pharmaceuticals report, "Immunicum AB - Product Pipeline Review - 2013" provides data on the Immunicum AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 12:14 pm CST
Global Market Direct's pharmaceuticals report, "Maruho Co., Ltd. - Product Pipeline Review - 2013" provides data on the Maruho Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 11:36 am CST
Global Markets Direct's, 'Acute Promyelocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Promyelocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 11:32 am CST
Global Market Direct's pharmaceuticals report, "Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Anacor Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 11:14 am CST
Optina (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 10:18 am CST
Global Market Direct's pharmaceuticals report, "Biofrontera AG - Product Pipeline Review - 2013" provides data on the Biofrontera AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 9:56 am CST
Global Market Direct's pharmaceuticals report, "BerGenBio AS - Product Pipeline Review - 2013" provides data on the BerGenBio AS's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Thursday, February 13, 2014 at 9:54 am CST
Global Markets Direct's, 'Food Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Food Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Food Allergy. Food Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 2:45 pm CST
Global Market Direct's pharmaceuticals report, "Japan Tobacco Inc. - Product Pipeline Review - 2013" provides data on the Japan Tobacco Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 2:45 pm CST
Global Market Direct's pharmaceuticals report, "Gamida Cell Ltd. - Product Pipeline Review - 2013" provides data on the Gamida Cell Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 2:16 pm CST
Global Market Direct's pharmaceuticals report, "Heat Biologics, Inc. - Product Pipeline Review - 2013" provides data on the Heat Biologics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 2:08 pm CST
Global Market Direct's pharmaceuticals report, "Biotecnol, Inc. - Product Pipeline Review - 2013" provides data on the Biotecnol, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Wednesday, February 12, 2014 at 2:08 pm CST
Global Market Direct's pharmaceuticals report, "Molecular Partners AG - Product Pipeline Review - 2013" provides data on the Molecular Partners AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research